These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1756422)

  • 1. Vasodilator therapy: interaction of nitrates with angiotensin-converting enzyme inhibitors.
    Juggi JS; Koenig-Berard E; Vitou P
    Can J Cardiol; 1991 Nov; 7(9):419-25. PubMed ID: 1756422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiol compounds and organic nitrates.
    Boesgaard S
    Dan Med Bull; 1995 Nov; 42(5):473-84. PubMed ID: 8747803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin converting enzyme inhibitors on tolerance of nitroglycerin.
    Fang Z; Li Y; Liu D; Li Y; Hao F; Liu Z
    Chin Med J (Engl); 1995 Dec; 108(12):919-22. PubMed ID: 8728945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactivation of organic nitrates and the mechanism of nitrate tolerance.
    Klemenska E; Beresewicz A
    Cardiol J; 2009; 16(1):11-9. PubMed ID: 19130411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril does not prevent nitroglycerin tolerance in heart failure.
    Dupuis J; Lalonde G; Bichet D; Rouleau JL
    Can J Cardiol; 1990 Sep; 6(7):281-6. PubMed ID: 2121325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiplatelet effects of nitrates: is it of clinical significance in patients with cardiovascular disease?
    Zhou RH; Frishman WH
    Cardiol Rev; 2010; 18(4):198-203. PubMed ID: 20539103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vasodilator agents in chronic heart failure: which is the best option?].
    Corbalán R; Kunstmann S; Jalil J
    Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of angina pectoris therapy with nitrates].
    Silber S
    Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between organic nitrates and thiol groups.
    Abrams J
    Am J Med; 1991 Sep; 91(3C):106S-112S. PubMed ID: 1928200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tolerance of nitrate derivatives: pharmacologic and clinical aspects].
    Unger P; Bethume P; Berkenboom G; Degré S
    Rev Med Brux; 1989 Mar; 10(3):82-8. PubMed ID: 2652239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of glyceryl trinitrate: beyond vascular nitrate tolerance.
    Csont T; Ferdinandy P
    Pharmacol Ther; 2005 Jan; 105(1):57-68. PubMed ID: 15626455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac failure and nitrates].
    Galinier M; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1997; 46(7):415-9. PubMed ID: 9452775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrates and angina pectoris.
    Parker JO
    Am J Cardiol; 1993 Sep; 72(8):3C-6C; discussion 6C-8C. PubMed ID: 8372799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS
    Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrates versus angiotensin-converting enzyme inhibitors for congestive heart failure.
    Cohn JN
    Am J Cardiol; 1993 Sep; 72(8):21C-24C; discussion 24C-26C. PubMed ID: 8372797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacologic interactions with nitrates in patients with, or at risk of, cardiac decompensation].
    Filardi PP; Chiariello M
    G Ital Cardiol; 1996 Sep; 26(9):1085-8. PubMed ID: 9036050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.